Sinloc and Fondaco sell Società di Biotecnologie

By scomunicare_sinloc 22 May 2018
Home  /  News  /  Sinloc and Fondaco sell Società di Biotecnologie

Sinloc and Fondaco SGR sold Società di Biotecnologie S.p.A. to Holding Infrastrutture S.r.l. and infrastructure holding company that is part of the Ersel Group.

Società di Biotechnologie is an SPV constituted in 2003 by Sinloc, Finpiemonte Partecipazion S.p.A., DE-GA S.p.A. and Iren S.p.A. following a tender offer for the project financing for the construction of the New School of Biotechnology in Turin on behalf of the University of Turin. The total investment in the project was approximately € 20 million with construction finishing in September 2006. The building is now home to more than 1000 students and 200 instructors who enjoy the use of the classrooms, laboratories, and services.

Sinloc not only invested in Società di Biotechnologie but also supported its growth through a variety of advisory activities.

this post was shared 0 times